{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:13:53Z","timestamp":1775146433505,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jconrel.2011.08.002","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T12:15:42Z","timestamp":1312805742000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy"],"prefix":"10.1016","volume":"157","author":[{"given":"Kuangshi","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jind\u0159ich","family":"Kope\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2011.08.002_bb0005","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J. Clin"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMra0708875","article-title":"Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma","volume":"359","author":"Cheson","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0015","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.med.59.060906.220345","article-title":"A decade of Rituximab: improving survival outcomes in non-Hodgkin's lymphoma","volume":"59","author":"Molina","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0025","first-page":"4906","article-title":"Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies","volume":"49","author":"Press","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12026-009-8121-x","article-title":"Strategies to enhance rituximab anti-tumor activity in the treatment of CD20-positive B-cell neoplasms","volume":"46","author":"Riaz","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0035","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0161-5890(88)90047-8","article-title":"Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B-lymphocytes","volume":"25","author":"Tedder","year":"1988","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","article-title":"CD20: a regulator of cell-cycle progression of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V69.2.584.584","article-title":"Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas","volume":"69","author":"Press","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0050","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0055","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.4049\/jimmunol.135.6.3795","article-title":"The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle","volume":"135","author":"Golay","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1083\/jcb.121.5.1121","article-title":"Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes","volume":"121","author":"Bubien","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1365-2567.2002.01495.x","article-title":"CD20-mediated apoptosis: signalling through lipid rafts","volume":"107","author":"Deans","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0070","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood.V91.5.1644","article-title":"Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies","volume":"91","author":"Shan","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/bcmd.2000.0287","article-title":"Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis","volume":"26","author":"Hofmeister","year":"2000","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0080","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V97.5.1392","article-title":"Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin","volume":"97","author":"Ghetie","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0085","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1158\/1078-0432.CCR-05-0554","article-title":"Generation of rituximab polymer may cause hyper-cross-linking-induced apoptosis in non-Hodgkin's lymphomas","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0090","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0095","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0100","first-page":"1763","article-title":"Clinical status and optimal use of rituximab for B-cell lymphomas","volume":"12","author":"McLaughlin","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0105","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"Ann. Oncol."},{"issue":"Suppl 2","key":"10.1016\/j.jconrel.2011.08.002_bb0110","first-page":"S1","article-title":"Mechanism of action of rituximab","volume":"12","author":"Maloney","year":"2001","journal-title":"Anticancer Drugs"},{"issue":"1 Suppl. 2","key":"10.1016\/j.jconrel.2011.08.002_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2003.50025","article-title":"The mechanism of action of rituximab in the elimination of tumor cells","volume":"30","author":"Johnson","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(03)00164-7","article-title":"Smart and genetically engineered biomaterials and drug delivery systems","volume":"20","author":"Kope\u010dek","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0125","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1002\/pola.23607","article-title":"Hydrogels. From soft contact lenses and implants to self-assembled nanomaterials","volume":"47","author":"Kope\u010dek","year":"2009","journal-title":"J. Polym. Sci. A1 Polym. Chem."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.actbio.2008.10.001","article-title":"Peptide-directed self-assembly of hydrogels","volume":"5","author":"Kope\u010dek","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2011.03.030","article-title":"Conformational consequences of cooperative binding of a coiled-coil peptide motif to poly(N-(2-hydroxypropyl) methacrylamide) HPMA copolymers","volume":"153","author":"Griffiths","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/17092","article-title":"Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains","volume":"397","author":"Wang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1021\/bm051002k","article-title":"Refolding hydrogels self-assembled from HPMA graft copolymers by antiparallel coiled-coil formation","volume":"7","author":"Yang","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/bm701001f","article-title":"Dynamic light scattering study of the self-assembly of HPMA hybrid graft copolymers","volume":"9","author":"Yang","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/anie.200906232","article-title":"Drug-free macromolecular therapeutics: Induction of apoptosis by coiled-coil-mediated cross-linking of antigens on the cell surface","volume":"49","author":"Wu","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/bc800351m","article-title":"Synthesis and evaluation of multivalent branched HPMA copolymer-Fab\u2032 conjugates targeted to B-cell antigen CD20","volume":"20","author":"Johnson","year":"2009","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0165","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V80.9.2315.2315","article-title":"The antitumor activity of an anti-CD22 Immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin","volume":"80","author":"Ghetie","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0170","first-page":"6567","article-title":"Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline conjugate","volume":"9","author":"Griffiths","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0175","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1182\/blood-2009-12-257386","article-title":"In vivo targeting of B-cell lymphoma with glycan ligands of CD22","volume":"115","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0180","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.biomaterials.2004.04.018","article-title":"Protein array method for assessing in vitro biomaterial-induced cytokine expression","volume":"26","author":"Li","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0185","first-page":"5866","article-title":"Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model","volume":"9","author":"Hernandez-Ilizaliturri","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0142-9612(84)90048-6","article-title":"Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice","volume":"5","author":"\u0158\u00edhov\u00e1","year":"1984","journal-title":"Biomaterials"},{"issue":"Suppl. 9","key":"10.1016\/j.jconrel.2011.08.002_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/macp.1985.020091985103","article-title":"Immunogenicity of N-(2-hydroxypropyl)methacrylamide copolymers","author":"\u0158\u00edhov\u00e1","year":"1985","journal-title":"Makromol. Chem."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/088391158600100103","article-title":"Activity of complement in the presence of N-(2-hydroxypropyl)methacrylamide copolymers","volume":"1","author":"\u0160ime\u010dkov\u00e1","year":"1986","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1163\/156856200743454","article-title":"HPMA copolymer-modified avidin: immune response","volume":"11","author":"Hart","year":"2000","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0142-9612(84)90062-0","article-title":"Controlled biodegradability of polymers \u2014 a key to drug delivery systems","volume":"5","author":"Kope\u010dek","year":"1984","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0215","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2675::AID-CNCR45>3.0.CO;2-6","article-title":"Pretargeting","volume":"80","author":"Goodwin","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2011.08.002_bb0220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0734-9750(01)00065-9","article-title":"Advances in pretargeting technology","volume":"19","author":"Goodwin","year":"2001","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0225","first-page":"1087","article-title":"Amplification targeting: A modified pretargeting approach with potential for signal amplification \u2014 proof of a concept","volume":"45","author":"He","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2011.08.002_bb0230","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1158\/0008-5472.CAN-08-0037","article-title":"Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody","volume":"68","author":"Sharkey","year":"2008","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911005700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911005700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:25:24Z","timestamp":1759159524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911005700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0168365911005700"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.08.002","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coiled-coil based drug-free macromolecular therapeutics: In vivo efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}